Kidney Stones: Types, Causes, the Calcium Paradox, and Prevention

Eleven Percent Will Form a Stone

Nephrolithiasis affects approximately 11% of men and 6% of women in the United States over their lifetime, with a recurrence rate of 50% within 5 years after a first episode, according to the National Kidney Foundation. Emergency department visits for kidney stones cost the US healthcare system approximately $5.3 billion annually (2015 data). The condition is not monolithic: four chemically distinct stone types exist, each with different causes, metabolic risk factors, and prevention strategies. Treating every kidney stone as a dietary oxalate problem — the common assumption — leads to wrong advice and recurrence.

Four Stone Types: Causes and Chemistry

The Calcium Paradox

The most counterintuitive fact in urological nutrition: dietary calcium reduces calcium oxalate stone risk. This appears to contradict basic chemistry — why would more calcium intake lower calcium stone formation? The mechanism operates in the gut, not the kidney. Dietary calcium binds oxalate in the intestinal lumen before absorption, forming insoluble calcium oxalate that is excreted in stool. When dietary calcium is restricted, gut oxalate absorption increases dramatically, urinary oxalate rises, and calcium oxalate crystals nucleate in the kidney. A pivotal trial by Borghi et al. (2002, NEJM) randomized recurrent male calcium stone formers to a low-calcium diet (400 mg/day) versus a normal-calcium, low-sodium, low-protein diet (1,200 mg calcium/day). At 5 years, the normal-calcium group had 51% fewer recurrences.

The recommendation from this trial: maintain calcium intake at 1,000–1,200 mg/day from food, not supplements. Calcium supplements taken outside of meals do not bind oxalate and may modestly increase urinary calcium — the opposite of the desired effect.

Uric Acid Stones: A Different Disease

Uric acid stones are unique: they are radiolucent (invisible on plain X-ray, visible on CT) and are often reversible without surgery. The key driver is persistently acidic urine, not hyperuricemia alone — many patients with gout and high serum uric acid never form stones, while others with normal serum uric acid form uric acid stones because their urine is consistently below pH 5.5. Metabolic syndrome and type 2 diabetes are strong risk factors due to insulin resistance-impaired ammonium excretion, which lowers urine pH. Oral potassium citrate alkalinizes urine to pH 6.5–7.0 and dissolves existing uric acid stones over weeks to months — a non-invasive, medication-based approach unique to this stone type.

Struvite Stones: Infection Stones

Struvite stones form exclusively in the context of urinary tract infection with urease-producing organisms. Urease splits urea into ammonia and CO₂, raising urinary pH above 7.0 and supersaturating phosphate and ammonium. Proteus mirabilis is the classic organism, though Klebsiella, Pseudomonas, and others are implicated. Struvite stones grow rapidly, often forming staghorn calculi that fill the entire renal pelvis and calyces. They require complete surgical removal (percutaneous nephrolithotomy) combined with antibiotic eradication of the causative organism; medical dissolution is not feasible. Women are disproportionately affected due to higher UTI incidence.

The 24-Hour Urine: Metabolic Evaluation

A single 24-hour urine collection captures the urinary supersaturation profile driving stone formation. It measures:

• Total urine volume (low volume is the most correctable risk factor — target >2.5 L/day)
• Urinary calcium (hypercalciuria defined as >200 mg/day women, >250 mg/day men)
• Urinary oxalate (>40 mg/day suggests hyperoxaluria — dietary, enteric, or primary)
• Urinary uric acid (>600 mg/day women, >800 mg/day men)
• Urinary citrate (hypocitraturia <320 mg/day — citrate inhibits crystal growth and aggregation)
• Urine pH (midday pH <5.5 points to uric acid stone risk; pH >7.0 suggests infection)

Two separate 24-hour collections on different dietary days are recommended for reliable interpretation. Guidelines from the American Urological Association recommend metabolic evaluation for all first-time stone formers with risk factors and all recurrent stone formers.

Cystinuria: A Genetic Outlier

Cystine stones result from an autosomal recessive defect in the amino acid transporter that reabsorbs cystine, ornithine, lysine, and arginine in the proximal tubule and intestine. Cystine is insoluble at normal urinary pH. Management requires extreme urine dilution (urine output >3–4 L/day), urine alkalinization above pH 7.5, and in refractory cases, thiol-binding drugs (D-penicillamine, tiopronin) that form soluble mixed disulfides. Cystine stones typically begin in childhood or young adulthood and require lifelong monitoring.

This article is for informational purposes only. Consult a qualified healthcare professional.